My buddy Vinnie works in the shipping department for the

New Post Public Reply Private Reply Replies (7) Message Board
Respert24
1,059
My buddy Vinnie works in the shipping department for the company that makes the Cytodyn coffee mugs. He was telling me that there was a mandatory 3rd shift added today. Everyone had to sign an NDA as well. Best I can tell there's been a huge order placed and it's "all hands on deck" until it's completed. He tells me they're supposed to be done by Wednesday afternoon. Don't worry about Vinnie for talking. He's union. They literally can't fire him.

Anyways, take that for what it's worth but I'm never wrong.

Someone. Wants. Mugs.

The bigger question is who?

Follow along and it will all make sense.

Back when I was a sophomore in high school my dad told me that I needed to work a factory job that summer. His reasoning was that I'd hate it and realize that going to college and doing a good job would help me avoid a hard life on third shift. He leaned on a friend to get me a job at a heat treat factory that dealt in springs and whatnot.

The first day I sat in a dirty chair in front of a soot-laden fan, separating sprockets into stacks of five while sweating like a boxer desperately trying to make weight.

Over and over.

And I needed that disgusting fan because half the plant was made up of massive ovens heat treating the springs and sprockets.

The second day I was standing a few feet in front of one of the ovens, feeding parts in and making sure they weren't touching each other. It was after the second day that I decided to quit. I didn't just quit though. I went to the local Manpower office and told them I wanted to find a factory job. A questionnaire led to a quick discussion and within a half hour or so I had a job at another factory that wasn't 125 degrees inside. This place made camshafts and I would tap or lathe shafts (heh, he said shafts) for the rest of the summer to keep the spirit of my old man's challenge.

It wasn't bad.

At one point in the summer we were all called up to the second floor where the offices and important people resided. Inside a huge conference room they announced some deal with Cummins and then the reps from Cummins handed out hats, shirts, and other random swag to celebrate. It was the launch of a new partnership.

So I can't help but think we've got ourselves an announcement on the horizon. Thus the mugs. Double thus the rescheduling

You just don't reschedule something like this unless it's for something more important. Now, we could come up with a lot of things that could be deemed more important and not all of them lead to immediate revenue or approval. But read these options and think about whether any of them pass the Cummins test...

- Important development surrounding EUA here in the US
- A foreign government stopped f'ing around and made the call to NP
- Partnership with big pharma on Covid indication
- Buyout
- FDA has asked to meet tomorrow about Cancer BTD
- FDA now asking for receptor vacancy data
- Scott Kelly needed asap as body double for Cpt Holt's husband on Brooklyn99
- Dr. Mahboob still introducing himself to the Brazilians & won't be done in time
- Spam folder messages from Mexico
- Shkreli escaped and NP is gathering funds to buy his Wu-Tang album
- JLang was in, JLang was out, and NP needs time to gather his thoughts.
- Swedes

I understand some of my due diligence is deeper than a lot of you go. But rest assured I crossed all of the I's and dotted every T. What remains are the only explanations.

So you tell me.

What the hell is going on?



1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles